千金药业：2025年净利润同比增长24.74%

Group 1 - The core viewpoint of the article is that Qianjin Pharmaceutical has reported its performance for the fiscal year 2025, showing modest growth in revenue and significant growth in net profit [1] Group 2 - The company achieved an operating income of 3.635 billion yuan, representing a year-on-year increase of 0.13% [1] - The net profit attributable to shareholders of the listed company was 288 million yuan, reflecting a year-on-year growth of 24.74% [1] - The basic earnings per share were 0.64 yuan, which is a year-on-year increase of 14.97% [1]